MMSI

No analysis generated yet. Run the pipeline for this company.

AI-extracted key facts from press releases and SEC filings. Significance 1–10.

6

PartnershipBullishPer-CompanyMar 30, 2026

Merit Medical partners with Medtronic to distribute ViaVerte nerve ablation system

▸Merit Medical enters distribution agreement with Medtronic for ViaVerte nerve ablation system
▸Partnership targets commercialization of minimally invasive chronic vertebrogenic low back pain solution
▸ViaVerte system leverages Medtronic’s established pain therapy distribution channels
▸MMSI shares trading 33% below analyst price target of $102
▸MMSI currently trading at 31.8x P/E versus industry average of 27.2x

Merit Medical Systems, Inc.